- £224.18m
- £449.43m
- £115.44m
- 67
- 83
- 32
- 66
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 89.9 | 83.8 | 87.9 | 103 | 115 |
Cost of Revenue | |||||
Gross Profit | 70.1 | 69.5 | 69.1 | 79 | 92.6 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 50 | 62.1 | 37.1 | 53.8 | 66.8 |
Operating Profit | 40 | 21.7 | 50.8 | 48.9 | 48.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 35.1 | 18.1 | 47 | 41.4 | 33.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 28.9 | 14.6 | 38 | 33.7 | 25.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 28.9 | 14.6 | 38 | 33.7 | 25.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 28.9 | 14.6 | 38 | 33.7 | 25.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.39 | 1.21 | 3.13 | 2.78 | 2.09 |
Dividends per Share |